Skip to main content

Table 1 Basic information of included studies

From: Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review

Study (years)

Species (Sex,n)

Model, anesthetic, weight

Interventions

Research methods

Virginia 2005

SD Rats

(Male,6/6)

6-OHDA induced (12μg, s.i.),

Isofiuorane,200 g

Curcumin (50 mg/kg dissolve in 10% of

Cremophor, gavage) for 4 days prior to lesioning

1. IHC

2. HPLC analysis

Pan 2007

C57BL/6 mice

(Male,30/10)

MPTP induced (30 mg/kg, i.p.),

Pentobarbital, 20 g

Curcumin (5, 50, 150 mg/kg dissolve in 1%

DMSO, i.p., respectively) for 4 days after surgery

1. IHC

2. WB analysis

Balusamy

2008

C57BL/6 mice

(Male,6/6)

BSO induced (3 mmol/kg, i.p.),

NR, 25 g

Curcumin (50 mg/kg dissolve in saline, i.p., bw per

day, for 1 and 3 days)

1. WB analysis

Rajeswari

2008

Swiss albino mice

(Male, 8/8)

MPTP induced (40 mg/kg, i.p.),

NR, 25–30 g

Curcumin (80 mg/kg dissolve in DMSO, i.p.)

for 7 days after surgery

1. HPLC analysis

Wang

2009

C57BL/6 mice

(Male,10/10)

MPTP induced (60 mg/kg, i.p.),

NR, 25–30 g

Curcumin (15 mg/kg dissolve in DMSO, i.p.) for 4 days prior to lesioning and after surgery

1. RT-PCR

2. HPLC analysis

Song 2010

C57BL/6 mice

(Male,10/10)

MPTP induced (30 mg/kg, i.p.),

NR, 23–25 g

Curcumin (50 mg/kg dissolve in DMSO, i.p.) for 5 days after surgery

1. Behavioral tests and WB

2. IHC

Peng 2010

SD Rats

(Male,20/20)

6-OHDA induced (16μg, s.i.),

Pentobarbital, 200–250 g

Curcumin (100 mg/kg dissolve in DMSO, gavage)

for 4 weeks after surgery

1. Behavioral tests

2. HPLC analysis

Zahra 2012

Wister rats

(Male,8/8)

Homocysteine induced

(2 mol/l, i.c.v.), NR, 250–300 g

Curcumin (50 mg/kg dissolve in saline, i.p.) for 10

days beginning 5 days prior to Hcy injection

1. Behavioral tests

2. IHC and Tunel staining

Du 2012

Wister rats

(Female,12/12)

6-OHDA induced (20μg, s.i.),

Chloral hydrate, 200–220 g

Curcumin pretreatment (200 mg/kg dissolve in saline) twice

a day for 24 days in total

1. HPLC analysis

2. IHC

Yu 2012

C57BL/6 mice

(Male,10/10)

MPTP induced (30 mg/kg, i.p.),

NR, 25 g

Curcumin (50 mg/kg dissolve in saline, i.p.) for 5 days

after surgery

1. Behavioral tests and WB 2. IHC and iron staining

Guo 2012

C57BL/6 mice (Male,30/10)

Lipidosome induced (1 μg/ml, s.i.), Chloral hydrate, 18-22 g

Curcumin (10, 20, 40 mg/kg dissolve in 1% DMSO, respectively, i.p.) for 4 days after surgery

1. Behavioral tests and WB 2. Elisa, RT-PCR, IFC 3. Luciferase assay

Tripanichkui 2013

ICR strain mice (Male,7/7)

6-OHDA induced (33μg, s.i.), Pentobarbital, NR

Curcumin (200 mg/kg dissolve in DMSO, i.p.) for 7 days after surgery

1. IHC 2. Quantification Kits

Ariana 2014

Swiss albino mice (Male, 16/8)

Inhalation Mn induced, NR, 45–55 g

Curcumin (500 or 1500 PPM) was supplemented in the diet for 14 weeks

1. Behavioral tests 2. Neurochemical Analysis

  1. MPTP 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine; SD Rats Sprague-Dawley rats; BSO Buthionine sulfoximine; 6-OHDA 6-hydroxy dopamine; NR no report; s.i. Striatum injection; i.p. intraperitoneally; i.c.v. intracerebroventricularly; DMSO Dimethyl sulfoxide; PBS Phosphate-buffered saline; IHC Immunohistochemistry; HPLC High-performance liquid chromatography; WB analysis western blot; RT-PCR Reverse transcription-polymerase chain reaction; IFC immunofluorescence; Elisa the enzyme-linked immunosorbent assay